The DTaP vaccine is administered to children from 6 weeks to 6 years of age to provide immunization against diphtheria, tetanus, and pertussis. This activity outlines the DTaP vaccine's indications, actions, and potential adverse effects as a valuable agent against these diseases. This activity will highlight the mechanism of action, administration, adverse effects, contraindications, and monitoring pertinent for healthcare team members in managing vaccine-preventable diseases.

**Objectives:**
- Review the pathophysiologies of diphtheria, tetanus, and pertussis.
- Identify the components of the DTaP vaccine, dosing, and site of injection.
- Summarize the recommendations of when to administer the DTaP vaccine. 
- Outline the interprofessional team strategies for improving care coordination and communication to advance immunization against diphtheria, tetanus, and pertussis and improve outcomes.